CONCLUDED Stock Market News From Sept. 17, 2025: Dow Gains After Fed Decision Last Updated: The dollar was edging higher but hovering near two-and-a-half-month lows as investors braced for a widely anticipated interest-rate cut from the Federal Reserve. The market prices a 97% chance of the Fed cutting rates by 25 basis points and a 3% chance of a 50bp cut in a decision later today, LSEG data show. A larger rate cut would put significant pressure on the dollar, Commerzbank's Thu Lan Nguyen said in a note. T ...

Group 1 - The VanEck CLO ETF (CLOI) received a buy rating in July 2025 due to strong fundamentals in the CLO market, high yields, and defensive characteristics [1] - The analyst has a Master's in Banking & Finance and a diverse background in corporate finance, M&A, and investment analysis, focusing on real estate, renewable energy, and equity markets [1] - The analyst specializes in financial modeling, valuation, and qualitative analysis, with experience in private equity, asset management, and real estate [1] Group 2 - The article emphasizes the importance of sharing insights and analysis with a global audience to foster informed decision-making [1]

PresentationJustin FurbyVice President of Investor Relations Hello. Thank you everybody. Welcome to Workday Rising. Welcome to Financial Analyst Day. This is our biggest conference ever. I don't know what the growth is, but I think it's pretty significant. I know this is our biggest Analyst Day event, which is good because this is by far the largest room that we've ever had. So thank you for not making it look too ridiculous and for showing up. We are glad that you made the trip out in all seriousness. Thi ...

Eli Lilly's international president Patrik Jonsson said on Wednesday the company had little clarity on the U.S. Food and Drug Administration's new fast-track review process, cautioning it was too earl... ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Core Viewpoint - Martin Shkreli, known as 'Pharma Bro,' has taken a short position against Opendoor Technologies Inc. at a price of $9.36 and plans to conduct a public due diligence campaign on the company [1][2][3]. Group 1: Shkreli's Actions and Intentions - Shkreli's short position marks his first trade in Opendoor, and he intends to conduct diligence calls with various stakeholders, including former employees and competitors [2][3]. - He has publicly labeled Opendoor as "an obvious short" and has warned investors against holding long positions in the stock [4]. - Shkreli draws parallels between Opendoor and his previous successful short call against Newegg Commerce Inc., suggesting he anticipates a similar decline for Opendoor [4][5]. Group 2: Market Context and Reactions - Opendoor's stock has seen significant volatility, having risen over 1,000% from its 52-week lows, which has led to its classification as a "meme stock" [5]. - On the day of Shkreli's announcement, Opendoor's stock fell 6.06% to $8.92 per share, although it has advanced 461.01% year-to-date [7]. - Other short-sellers, such as Andrew Left of Citron Research, have also expressed bearish views on Opendoor, describing it as "a science project in how to burn money" [5].

Commodity trader and investment company ResInvest Group said it is in talks to buy Datteln 4, the 1 gigawatt coal-fired power plant Uniper must sell as part of the German utility's government rescue i... ...

Martin Shkreli, also popularly known as ‘Pharma Bro,’ announced late Tuesday that he has taken a short position against iBuying real estate company Opendoor Technologies Inc. OPEN.Check out OPEN’s stock price here. Pharma Bro To Launch Public Due Diligence Against OPENIn a post on the social media platform X, Shkreli revealed he shorted the stock at $9.36, marking his first trade in the company. He also declared his intention to launch a public due diligence campaign into the firm.“This is the first trade I ...

Lazydays Holdings Inc. GORV saw a significant surge in its stock price, rising 22.79% in after-hours trading to $3.76, adding to a 24.90% gain during the regular trading session, according to Benzinga Pro data. This sharp increase followed the company's announcement that it had signed a letter of intent (LOI) for an acquisition by Campers Inn RV.Check out the current price of GORV stock here. Acquisition Details Drive Market ResponseCampers Inn RV plans to acquire nearly all of Lazydays’ assets and those of ...

CONCLUDED Stock Market News From Sept. 17, 2025: Dow Gains After Fed Decision Last Updated: 15 hours ago U.S. Treasury Yields Are Stable Ahead of Fed Rate Decision By Emese Bartha, Dow Jones Newswires Yields on U.S. Treasuries were stable in early trade as markets await the Federal Reserve's rate decision, most likely a 25-basis-point reduction. "The probability is very high that the Fed will cut by 25 basis points tonight, and a 50-basis point cut cannot fully be ruled out," said SEB Research's FX and fixe ...